Multiple Sclerosis and the Disability Tax Credit Canada 2026

Multiple sclerosis may support a DTC claim when symptoms markedly restrict walking, mental functions, or other daily activities. Eligibility depends on functional impact, not diagnosis alone.

Quick Answer

Yes, multiple sclerosis can qualify for the Disability Tax Credit Canada in 2026, most often under walking or mental functions. Both relapsing-remitting and progressive MS may qualify when fatigue, mobility, or cognitive symptoms markedly restrict daily activities at least 90% of the time. The cumulative effect rule often applies to MS claims.

Educational purposes only. Not tax or medical advice. Consult a qualified professional for advice specific to your situation.

How MS Can Qualify for the DTC

MS affects different people differently. CRA does not approve or deny based on diagnosis alone. The question is always: do your specific MS symptoms markedly restrict a basic activity of daily living 90% or more of the time

Common qualifying categories for MS include:

  • Walking: gait impairment, foot drop, spasticity, balance issues, or fatigue that severely limits walking distance
  • Dressing: fine motor impairment, spasticity, or fatigue preventing independent dressing
  • Mental functions: MS-related cognitive impairment ("MS fog"), memory, concentration, and executive function problems
  • Vision: optic neuritis causing lasting vision impairment
  • Bladder/bowel: severe neurogenic bladder or bowel dysfunction taking inordinate time to manage
  • Cumulative effect: multiple moderate restrictions combining to equal a marked restriction

Relapsing-Remitting MS and the 90% Rule

RRMS presents a unique challenge because symptoms fluctuate. CRA's 90% rule means restriction must exist most of the time. For RRMS:

  • Frequent or prolonged relapses that cumulatively exceed 90% of the year can qualify
  • Persistent inter-relapse impairment (fatigue, cognitive issues, heat sensitivity) that affects daily function can count toward the 90%
  • Accumulated neurological damage that causes baseline impairment between relapses is particularly important to document

Progressive MS (primary progressive, secondary progressive) typically has an easier path to qualification because restriction is more consistent and ongoing.

MS Fatigue as a DTC Factor

MS fatigue is often overlooked but can be one of the most disabling aspects of the condition. If MS fatigue is severe enough that it restricts walking, dressing, or other activities 90% of the time, it can support a DTC claim. Your neurologist should document the severity and functional impact of MS fatigue specifically, as generic fatigue documentation is often insufficient.

Key Documentation for MS DTC

  • Neurologist report detailing current functional limitations (not just MRI findings or diagnosis)
  • Expanded Disability Status Scale (EDSS) score from your neurologist, scores of 4.0 and above typically indicate significant mobility restriction
  • Physiotherapy assessment of walking capacity and balance
  • Occupational therapy report on activities of daily living
  • Neuropsychological testing if cognitive impairment is a primary symptom
  • Documentation of MS fatigue severity and functional impact
  • Records of disease-modifying therapy and its effects on function

2026 DTC Amounts for MS

If approved: federal credit $1,448 per year. Combined with provincial: $2,047 to $3,708 per year. Retroactive credits can be significant, but the final amount depends on the CRA-approved years, province, taxable income, transfer rules, and prior returns.

Estimate Your MS DTC Credit

Real multiple sclerosis Filing Scenario

The following example is illustrative. It describes a typical filing flow and does not predict any individual outcome.

A Toronto-area resident with relapsing-remitting multiple sclerosis met with her neurologist to complete Part B. The neurologist documented walking restriction (limited endurance, frequent rest required) and cognitive fatigue affecting mental functions, both anchored to MRI findings and EDSS scoring. Part B addressed section 6 explicitly, certifying that the cumulative effect takes more than 14 hours per week of extra support and time across both restrictions. The Notice of Determination arrived 12 weeks after submission, approving the DTC retroactive to 2022.

Documentation That Works for multiple sclerosis Part B

What worked in this Part B: cumulative-effect attestation combining walking and mental functions, plus objective neurological findings (EDSS score, MRI). MS claims succeed when both motor and cognitive aspects are documented under section 6, rather than relying on a single category. See our cumulative effects rule guide for the technical framework CRA reviewers apply, and our DTC denied appeal guide if a previous application was rejected.

Frequently Asked Questions

CRA assesses function "with appropriate therapy," which includes your disease-modifying medications. If your MS medications allow near-normal function, you may not currently qualify. However, if significant impairment remains despite optimal treatment, the claim can still succeed. Many people with MS who take medication still experience fatigue, cognitive issues, or mobility limitations that meet the threshold.

If you are currently asymptomatic or minimally impaired, you likely would not qualify at this time. DTC eligibility is based on functional impairment, not diagnosis alone. However, you should consider applying as your condition progresses, and keep in mind that you can apply retroactively later for years when your impairment was significant.

Your neurologist is the most appropriate certifier for MS, as they have documented your diagnosis, monitoring, and functional status over time. A general practitioner who manages your MS care can also certify. The certifier should be able to speak specifically to your functional limitations, not just your disease status or MRI findings.

Yes. If your MS was severe enough to qualify in prior years, you can apply retroactively for up to 10 years. Your neurologist can certify the start date of your qualifying impairment based on clinical records and EDSS scores from prior visits. This is particularly valuable for progressive MS patients who have had years of restriction before applying.

Official Sources and Related Guides

This condition guide is based on CRA's Disability Tax Credit criteria and official Form T2201 instructions. Use it with our DTC eligibility guide, T2201 form guide, and DTC calculator. For questions about your own facts, contact Disability Tax Credits Canada or speak with a qualified Canadian tax professional.

How CRA Reviews Multiple Sclerosis Evidence

For multiple sclerosis claims, the CRA does not approve or deny the Disability Tax Credit based on the diagnosis name alone. The reviewer looks for a severe and prolonged impairment that creates a marked restriction in one basic activity of daily living, a cumulative effect across more than one activity, or qualifying life-sustaining therapy. The strongest files connect the medical history to everyday function using dates, treatment history, frequency, and examples from ordinary routines.

Good multiple sclerosis documentation should explain what still happens after treatment, accommodations, medication, assistive devices, or family support are already in place. This helps avoid a common weakness in DTC applications: describing symptoms without showing how those symptoms restrict daily activities at least 90 percent of the time.

  • Functional examples: describe what the person cannot do, needs extra time to do, or can only do with support.
  • Frequency and duration: connect the restriction to CRA's 90 percent and 12-month standards where applicable.
  • Clinical evidence: include treatment history, specialist notes, test results, medication trials, therapy records, or assistive-device use when relevant.
  • Tax context: use the DTC calculator only as an estimate after understanding eligibility through the main DTC guide.

Building a Safer Multiple Sclerosis Application Path

Before submitting Form T2201, compare the medical practitioner's Part B wording against CRA's published categories. If the evidence is borderline, our cumulative effects guide can help identify whether multiple moderate restrictions combine into a marked overall limitation. If a previous claim was denied, review the exact denial reason before sending new information; a stronger appeal usually responds to the CRA's stated concern rather than repeating the first application.

Estimate Your MS DTC Amount